Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-03-23

FDA Approved: WYMZYA FE — Original Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved WYMZYA FE, a generic combined oral contraceptive containing norethindrone and ethinyl estradiol, from Lupin Pharmaceuticals, under its Original App…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • WYMZYA FE (NORETHINDRONE AND ETHINYL ESTRADIOL)

Snippet

ORIG AP for WYMZYA FE (NORETHINDRONE AND ETHINYL ESTRADIOL)